Sinai Health has unveiled its inaugural Research Strategic Plan (2026–2031). It reflects a deep commitment to embedding research and innovation...
firstever
For the first time ever, researchers are studying the home use of non-hallucinogenic/micro-dose levels of psilocybin — the active compound...
